Lindbrook Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13.1K | Buy |
206
+50
| +32% | +$3.19K | ﹤0.01% | 1538 |
|
|
2024
Q4 | $19K | Sell |
156
-11
| -7% | -$1.34K | ﹤0.01% | 1313 |
|
|
2024
Q3 | $20.9K | Buy |
167
+43
| +35% | +$5.37K | ﹤0.01% | 1280 |
|
|
2024
Q2 | $19.6K | Sell |
124
-15
| -11% | -$2.37K | ﹤0.01% | 1251 |
|
|
2024
Q1 | $18K | Buy |
139
+69
| +99% | +$8.93K | ﹤0.01% | 1266 |
|
|
2023
Q4 | $6.75K | Buy |
70
+28
| +67% | +$2.7K | ﹤0.01% | 1733 |
|
|
2023
Q3 | $5.09K | Buy |
42
+11
| +35% | +$1.33K | ﹤0.01% | 1759 |
|
|
2023
Q2 | $3.55K | Sell |
31
-9
| -23% | -$1.03K | ﹤0.01% | 1947 |
|
|
2023
Q1 | $5.51K | Buy |
40
+12
| +43% | +$1.65K | ﹤0.01% | 1815 |
|
|
2022
Q4 | $3.63K | Sell |
28
-22
| -44% | -$2.85K | ﹤0.01% | 1970 |
|
|
2022
Q3 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 1598 |
|
|
2022
Q1 | – | Sell |
-49
| Closed | -$4K | – | 2616 |
|
|
2021
Q4 | $4K | Hold |
49
| – | – | ﹤0.01% | 1606 |
|
|
2021
Q3 | $5K | Buy |
49
+42
| +600% | +$4.29K | ﹤0.01% | 1260 |
|
|
2021
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1826 |
|
|
2021
Q1 | – | Sell |
-11
| Closed | -$2K | – | 1937 |
|
|
2020
Q4 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 1508 |
|
|
2020
Q1 | – | Sell |
-150
| Closed | -$19K | – | 1872 |
|
|
2019
Q4 | $19K | Sell |
150
-150
| -50% | -$19K | 0.01% | 762 |
|
|
2019
Q3 | $23K | Buy |
+300
| New | +$23K | 0.01% | 657 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$35K | – | 1501 |
|
|
2019
Q1 | $35K | Buy |
+300
| New | +$35K | 0.01% | 517 |
|